Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 27,548 | 23,407 | 32,565 | 38,630 | 43,760 |
| Operating Income | -27,548 | -23,407 | -32,565 | -38,630 | -43,760 |
| Other Income | -34,745 | -3,622 | -8,742 | -4,611 | 37,765 |
| Pre-tax Income | -62,293 | -27,029 | -41,307 | -43,241 | -5,995 |
| Net Income Continuous | -62,293 | -27,029 | -41,307 | -43,241 | -5,995 |
| Net Income | $-62,293 | $-27,029 | $-41,307 | $-43,241 | $-5,995 |
| EPS Basic Total Ops | -1.02 | -0.56 | -0.89 | -1.03 | -0.20 |
| EPS Basic Continuous Ops | -1.02 | -0.56 | -0.89 | -1.03 | -0.20 |
| EPS Diluted Total Ops | -1.02 | -0.56 | -0.89 | -1.03 | -0.20 |
| EPS Diluted Continuous Ops | -1.02 | -0.56 | -0.89 | -1.03 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.53 | -0.56 | -0.89 | -1.03 | -1.47 |
| EBITDA(a) | $-28,604 | $-24,150 | $-32,368 | $-37,931 | $-42,974 |